arrow
H

Helen L. Leavis

Utrecht University Medical Center
H指数:36
被引数:5,168

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Salivary polyreactive and SARS-CoV-2-specific antibody responses following SARS-CoV-2 infection and vaccination in healthcare workers

SARS-CoV-2感染和疫苗接种后,医务工作者唾液中多反应性和SARS-CoV-2特异性抗体应答

2026-08-010
PRE
Repurposing leflunomide and hydroxychloroquine to treat Sjögren's disease (RepurpSS-II): a randomised, double-blind, placebo-controlled, phase 2b trial

利福诺米和羟氯喹的再利用治疗舍格伦综合征(RepurpSS-II):一项随机、双盲、安慰剂对照的2b期临床试验

2026-05-200
PRE
αβT/CD19-depleted Allogeneic Stem Cell Transplantation in Adults with Inborn Errors of Immunity

αβT/CD19耗竭的异基因造血干细胞移植在免疫先天性缺陷成人中的应用

2026-02-030
OAAI
Proteins linked to type II interferon response in Sjögren’s disease: novel indicators for disease monitoring and predicting treatment response to leflunomide and hydroxychloroquine combination therapy

与Sjögren’s disease中II型干扰素反应相关的蛋白质:疾病监测和治疗对来氟米特与羟氯喹联合疗法反应的新型指标

2025-10-170
OAAI
Correction to: Self-reported Clinical Outcomes and Quality of Life in Agammaglobulinemia: the Importance of an Early Diagnosis

更正:Agammaglobulinemia患者自报的临床结局和生活质量:早期诊断的重要性

2025-10-090
OA
Proceedings of the Second Artificial Intelligence in Primary Immunodeficiencies (AIPI) Meeting

第二届人工智能在原发性免疫缺陷中的应用(AIPI)会议论文集

2025-09-170
OAAI
Self-reported Clinical Outcomes and Quality of Life in Agammaglobulinemia: the Importance of an Early Diagnosis

自报的临床结局和生活质量在无丙种球蛋白血症中的研究:早期诊断的重要性

2025-08-250
OAAI
Tocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trial

托珠单抗、萨利鲁单抗和阿那白滞素在危重症COVID-19患者中的应用:一项随机、对照、开放标签、适应性平台试验

THORAX
IF7.7
2025-05-130
PRE
Gut microbial dysbiosis, IgA, and Enterococcus in common variable immunodeficiency with immune dysregulation

肠道微生物失调、IgA 和肠球菌在伴有免疫失调的共同变异型免疫缺陷中的作用

2025-01-162
OA
PAROTIDTRANSCRIPTOMIC NETWORKS ASSOCIATED WITH B CELL HYPERACTIVITY, AND VIRUS/IFN ACTIVITY ARE TARGETED BY LEFLUNOMIDE/HYDROXYCHLOROQUINE THERAPY IN SJÖGREN PATIENTS AND ARE CAPTURED BY A CIRCULATING PROTEOME

与B细胞高活性及病毒/IFN活性相关的腮腺转录组网络,在Sjögren患者中受到来氟米特/羟氯喹疗法的靶向作用,并由循环蛋白质组捕获。

2024-06-010
PRE